To study the burden of patients’ symptoms other than pain and their treatment by Portuguese palliative care teams.
Methods:
Of the 21 Portuguese palliative care teams identified, 10 accepted to participate. Data from all patients observed on the 18th week of 2011 were collected.
Results:
One hundred and sixty-four patients were included in this study. One hundred and fifty-one patients (92%) had cancer. The patients’ median age was 71 years (16-95) and 84 (51%) were females. The main symptoms were fatigue (116 [85%]) and depression/sadness (107 [65%]). Many different drugs were used for symptom control and other aims. Symptoms and drugs used here are similar to those practiced in other countries.
Conclusion:
The practice of palliative care in Portugal seems to be similar to those in other countries.
GonçalvesJA. A Portuguese palliative care unit. Support Care Cancer. 2001;9(1):4–7.
2.
KaasaSTorvikKChernyNHanksGde ConnoF. Patient demographics and centre description in European palliative care units. Palliat Med. 2007;21(1):15–22.
3.
TeunissenSCWeskerWKruitwagenCde HaesHCVoestEEde GraeffA. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34(1):94–104.
4.
GlarePVirikKJonesM. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ. 2003;327(7408):195–198.
5.
PeduzziPConcatoJKemperEHolfordTRFeinsteinAR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–1379.
6.
GonçalvesFAlmeidaAAntunesC. A cross-sectional survey of pain in palliative care in Portugal. Support Care Cancer. 2013;21(7):2033–2039.
7.
GonçalvesFAlmeidaAAntunesC. A cross-sectional survey of the activity of palliative care teams in Portugal. Am J Hosp Palliat Care. 2013;30(7):648–651.
8.
LaugsandEAKaasaSde ConnoFHanksGKlepstadP. Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network. J Opioid Manage. 2009;5(1):11–21.
9.
ChiuTYHuWYChenCY. Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer. 2000;8(4):311–313.
10.
PortenoyRKThalerHTKornblith. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326–1336.
11.
HomsiJWalshDRiveraN. Symptom evaluation in palliative medicine: patient report vs. systematic assessment. Support Care Cancer. 2006;14(5):444–453.
12.
JohnsenATPetersenMAPedersenLGroenvold. Development and initial validation of the Three-Levels-of-Needs Questionnaire for self-assessment of palliative needs in patients with cancer. J Pain Symptom Manage. 2011;41(6):1025–1039.
13.
CamposMOHassanBJRiechelmannRDel GiglioA. Cancer-related fatigue: a practical review. Ann Oncol. 2011;22(6):1273–1279.
14.
VoglDRosenfeldBBreitbartW. Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage. 1999;18(4):243–262.
15.
JongEOudhoffcLAEpskampC. Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era. AIDS. 2010;24(10):1387–1405.
16.
SolanoJPGomesBHigginsonIJ. Acomparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58–69.
17.
McMillanSCSmallBJ. Symptom distress and quality of life in patients with cancer newly admitted to hospice home care. Oncol Nurs Forum. 2002;29(10):1421–1428.
BerneyAStiefelFMazzocatoCBuclinT. Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants. Support Care Cancer. 2000;8(4):278–286.
20.
HotopfMChidgeyJAddington-HallJLyKL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16(2):81–97.
21.
StiefelFTrillMBerneyAOlarteJRazaviD. Depression in palliative care: a pragmatic report from the Expert Working Group of the European Association for Palliative Care. Support Care Cancer. 2001;9(7):477–488.
22.
Lloyd-WilliamsMHughesJG. The management of anxiety in advanced disease. Prog Palliat Care. 2008;16(1):47–50.
23.
ChangVTHwangSSFeuermanMKasimisBSThalerHT. The memorial symptom assessment scale short form (MSAS-SF): validity and reliability. Cancer. 2000;89(5):1162–1171.
24.
TsaiJSWuCHChiuTYHuWUChenCY. Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med. 2006;20(6):617–622.
25.
KvaleEAShusterJL. Sleep disturbance in supportive care of cancer: a review. J Palliat Med. 2006;9(2):437–450.
26.
SelaRAWatanabeSNekolaichukCL. Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care. 2005;3(1):23–31.
27.
GlarePMillerJNikolovaTTickooR. Treating nausea and vomiting in palliative care: a review. Clin Interv Aging. 2011;6:243–259.
28.
MeeusenKvan den BlockLEchteldNA. End-of-life care and circumstances of death in patients dying as a result of cancer in Belgium and the Netherlands: a retrospective comparative study. J Clin Oncol. 2011;29(32):4327–4334.
29.
RodriguezKLHanlonJTPereraSJaffeEJSevickMA. A cross-sectional analysis of the prevalence of undertreatment of nonpain symptoms and factors associated with undertreatment in older nursing home hospice/palliative care patients. Am J Geriatr Pharmacother. 2010;8(3):225–232.
30.
JohnsenATPetersenMAPedersenLGroenvoldM. Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med. 2009;23(6):491–501.
31.
De LimaLDoyleD. The International Association for Hospice and Palliative Care list of essential medicines for palliative care. J Pain Palliat Care Pharmacother. 2007;21(3):29–36.
32.
GaertnerJRubergKSchlesigerGFrechenSVoltzR. Drug interactions in palliative care—it’s more than cytochrome P450. Palliat Med. 2011;26(6):813–825.
33.
BainKT. Use of proton pump inhibitors in hospice care: understanding the risks. Palliat Med Matters. 2011;5(1):1–6.
ClaytonJFardellBHutton-PottsJWebbDChyeR. Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Palliat Med. 2003;17(1):44–48.
